Recent Posts
- Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
- Scancell FY25 Interim Results Presentation
- CEO Phil L’Huillier gives update on Scancell progress to Proactive
- FY25 Interim Results: Products, People and Progress
- H125 reaffirms funds are sufficient to deliver key data
Recent Comments
No comments to show.